Host-directed Drug Repurposing
Host-Directed Drug Repurposing is a drug repurposing strategy that targets host cellular factors and pathways to modulate infectious disease outcomes, distinguishing itself from pathogen-directed approaches by focusing on the host's biological mechanisms rather than microbial components.
14
Publications
597
Citations
117
Authors
48
Institutions
Publications per year
2017–2026
13
14
Sebastian Schloer, Linda Brunotte, Angeles Mecate‐Zambrano et al. · British Journal of Pharmacology · 2021 · 110 citations · Full text
Host-directed drug therapy for tuberculosis
Reto Guler, Frank Brombacher · Nature Chemical Biology · 2015 · 48 citations
1–5 of 14
117
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 117
48

University of Roehampton
London, United Kingdom
2 h-index
13 publications
442 citations

Universidad de León
León, Spain
2 h-index
2 publications
58 citations
Maison des Sciences sociales et des Humanités de Dijon
Dijon, France
1 h-index
2 publications
72 citations

Children's National
Washington, United States
1 h-index
3 publications
66 citations
Inserm
Paris, France
1 h-index
3 publications
108 citations
Ankara Yıldırım Beyazıt University
Ankara, Türkiye
1 h-index
1 publications
36 citations

Sun Yat-sen University
Guangzhou, China
1 h-index
1 publications
87 citations

Chinese Academy of Sciences
Beijing, China
1 h-index
1 publications
36 citations
1–8 of 48
3 publications · 90 citations
3
h-index
2 publications · 58 citations
2
h-index
1 publications · 48 citations
1
h-index
1 publications · 55 citations
1
h-index
BJP · 1 publications · 110 citations
1
h-index
1–5